Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quality of life in treatment of AK: Treatment burden of ingenol mebutate gel is small and short lasting
William C. Hanke, Jenny M. Norlin, Kim Knudsen, et al.
Journal of Dermatological Treatment (2016) Vol. 27, Iss. 5, pp. 450-455
Closed Access | Times Cited: 17

Showing 17 citing articles:

Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature
Adem Sav, Asiyeh Salehi, Frances S Mair, et al.
BMC Medical Research Methodology (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 85
Treatment considerations in actinic keratosis
Gary Goldenberg
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. S2, pp. 12-16
Open Access | Times Cited: 37
A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries
Jui Vyas, Jeffrey Johns, F.M. Ali, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 3, pp. 315-339
Open Access | Times Cited: 8
Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients
Hanna Norrlid, Jenny M. Norlin, Heidi Holmstrup, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 1, pp. 68-73
Open Access | Times Cited: 16
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp
Alise Balcere, Māra Rone Kupfere, Ingrīda Čēma, et al.
Medicina (2019) Vol. 55, Iss. 4, pp. 92-92
Open Access | Times Cited: 15
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis
Eggert Stockfleth, Mike Bastian
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 9, pp. 911-918
Closed Access | Times Cited: 11
A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest
Marc Bourcier, Linda Stein Gold, Lyn Guenther, et al.
Journal of Dermatological Treatment (2017) Vol. 28, Iss. 7, pp. 652-658
Closed Access | Times Cited: 10
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
Chi So, Anne Ε. Cust, Louisa G. Gordon, et al.
Skin Health and Disease (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 8
Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.
Brian Berman, Stephen K. Tyring, Walter K. Nahm, et al.
PubMed (2017) Vol. 10, Iss. 11, pp. 26-32
Closed Access | Times Cited: 5
Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire
Larissa S. Meier, Maria Schubert, Yasemin Azize Goksu, et al.
Dermatology (2018) Vol. 234, Iss. 1-2, pp. 51-59
Closed Access | Times Cited: 4
Diagnostic and Treatment Aspects of Actinic Keratoses. Summary of the Doctoral Thesis
Alise Balcere
(2024)
Open Access
Aktīnisko keratožu diagnostikas un ārstēšanas aspekti. Promocijas darbs
Alise Balcere
(2024)
Open Access
Aktīnisko keratožu diagnostikas un ārstēšanas aspekti. Promocijas darba kopsavilkums
Alise Balcere
(2024)
Open Access
Evaluation of Different Approaches in Managing Local Skin Reactions With the Use of Ingenol Mebutate 0.015% and 0.05% During the Treatment of Actinic Keratosis
Scott Freeman, Miriam Bettencourt, Meg Corliss, et al.
SKIN The Journal of Cutaneous Medicine (2020) Vol. 4, Iss. 5, pp. s65-s65
Open Access | Times Cited: 2
Full face ingenol mebutate for actinic keratosis: patient perspective
Eleni Anthony, Karyn Lun, Saxon D. Smith
International Journal of Dermatology (2018) Vol. 58, Iss. 1
Open Access | Times Cited: 1
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
Eggert Stockfleth, Catherine Α. Harwood, C. Serra‐Guillén, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 2, pp. 433-442
Closed Access
Page 1

Scroll to top